CIK 0001196298
- Non-accelerated filer
- Smaller reporting company
NEPHROS INC
Sign in to watch- Ticker
- NEPH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133971809
- Phone
- +1 201-343-5202
- Business address
- 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
- 4 Grant or award Chief Marketing Officer acquired 40,557 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 14,754 shares (option exercise)
- 4 Grant or award Director acquired 3,196 shares (grant or award)
- 4 Grant or award Director acquired 3,666 shares (grant or award)
- 4 Grant or award Director acquired 3,666 shares (grant or award)
- 4 Grant or award Director acquired 5,921 shares (grant or award)
- 4 Grant or award Director acquired 3,666 shares (grant or award)
- 4 Grant or award Director acquired 3,666 shares (grant or award)
- 4 Open-market buy Director bought 1,500 shares at $5.83 ($8,749)
- 4 Open-market buy President & CEO bought 1,000 shares at $5.87 ($5,867)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 166,667 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy COO/CFO bought 950 shares at $7.40 ($7,030)
- 4 Open-market buy CFO/COO bought 1,000 shares at $6.96 ($6,960)
- 4 Option exercise Director acquired 1,732 shares (option exercise)
- 4 Open-market buy President and CEO bought 2,500 shares at $6.65 ($16,625)
- 4 Open-market buy CFO/COO bought 1,000 shares at $6.70 ($6,700)
- 4 Open-market buy President and CEO bought 2,500 shares at $8.44 ($21,109)
Page 4 of 17 · 332 filings